Koninklijke Philips Research and Development Expenses 2010-2022 | PHG
Koninklijke Philips annual/quarterly research and development expenses history and growth rate from 2010 to 2022. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Koninklijke Philips research and development expenses for the quarter ending September 30, 2022 were $0.619B, a 24.4% increase year-over-year.
- Koninklijke Philips research and development expenses for the twelve months ending September 30, 2022 were $2.208B, a 7.9% increase year-over-year.
- Koninklijke Philips annual research and development expenses for 2022 were $2.216B, a 3.7% increase from 2021.
- Koninklijke Philips annual research and development expenses for 2021 were $2.137B, a 2.32% decline from 2020.
- Koninklijke Philips annual research and development expenses for 2020 were $2.188B, a 3.67% increase from 2019.
Koninklijke Philips Annual Research and Development Expenses (Millions of US $) |
2022 |
$2,216 |
2021 |
$2,137 |
2020 |
$2,188 |
2019 |
$2,110 |
2018 |
$2,077 |
2017 |
$1,994 |
2016 |
$2,236 |
2015 |
$2,140 |
2014 |
$2,173 |
2013 |
$2,302 |
2012 |
$2,328 |
2011 |
$2,242 |
2010 |
$2,093 |
2009 |
$2,275 |
Koninklijke Philips Quarterly Research and Development Expenses (Millions of US $) |
2022-09-30 |
$619 |
2022-06-30 |
$521 |
2021-06-30 |
$566 |
2020-06-30 |
$501 |
2019-06-30 |
$498 |
2018-06-30 |
$507 |
2017-06-30 |
$463 |
2016-12-31 |
$579 |
2016-09-30 |
$573 |
2016-06-30 |
$566 |
2016-03-31 |
$519 |
2015-12-31 |
$589 |
2015-09-30 |
$524 |
2015-06-30 |
$534 |
2015-03-31 |
$492 |
2014-12-31 |
$485 |
2014-09-30 |
$528 |
2014-06-30 |
$584 |
2014-03-31 |
$576 |
2013-12-31 |
$620 |
2013-09-30 |
$579 |
2013-06-30 |
$543 |
2013-03-31 |
$560 |
2012-12-31 |
$634 |
2012-09-30 |
$552 |
2012-06-30 |
$562 |
2012-03-31 |
$581 |
2011-12-31 |
$609 |
2011-09-30 |
$551 |
2011-06-30 |
$548 |
2011-03-31 |
$535 |
2010-12-31 |
$560 |
2010-09-30 |
$506 |
2010-06-30 |
$508 |
2010-03-31 |
$520 |
2009-12-31 |
$643 |
2009-09-30 |
$532 |
2009-06-30 |
$571 |
2009-03-31 |
$530 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Products Manufacturing |
$15.021B |
$18.786B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
|